Consulting Agreements in the Health Care Equipment & Supplies Industry

412 Contracts & Agreements

Browse by Company

ABIOMED Inc (2 contracts)
Accelerate Diagnostics, Inc (2)
ACCURAY INC (8)
Acutus Medical, Inc. (4)
AdvanSource Biomaterials Corp (6)
AETHLON MEDICAL INC (2)
AIT Therapeutics, Inc. (2)
Alphatec Holdings, Inc. (6)
ANTARES PHARMA, INC. (1)
Apollo Endosurgery, Inc. (2)
AquaMed Technologies, Inc. (3)
ARATANA THERAPEUTICS, INC. (1)
Arch Therapeutics, Inc. (1)
ARGOS THERAPEUTICS INC (3)
AtriCure, Inc. (1)
AV Therapeutics, Inc. (4)
Avinger Inc (1)
BARRIER THERAPEUTICS INC (1)
Bayhill Therapeutics, Inc. (3)
Becton Dickinson (1)
BioSig Technologies, Inc. (6)
Bioventus Inc. (1)
Blake Insomnia Therapeutics, Inc. (2)
Cadrenal Therapeutics, Inc. (2)
CALMARE THERAPEUTICS Inc (2)
Cardiovascular Systems Inc (5)
Cell MedX Corp. (5)
CESCA THERAPEUTICS INC. (2)
CHF Solutions, Inc. (2)
Chromocell Therapeutics Corp (1)
Civitas Therapeutics, Inc. (4)
Colfax CORP (3)
Conformis Inc (3)
CORNERSTONE THERAPEUTICS INC (5)
CryoLife, Inc. (1)
Cryoport, Inc. (1)
Cutera, Inc. (4)
CVRx, Inc. (1)
Cynapsus Therapeutics Inc. (1)
Cytosorbents Corp (3)
Danaher Corp. (2)
Dare Bioscience, Inc. (2)
DarioHealth Corp. (2)
DEXCOM INC (1)
DYNATRONICS CORP (2)
Echo Therapeutics, Inc. (6)
EKSO BIONICS HOLDINGS, INC. (1)
Electromedical Technologies, Inc (34)
Elicio Therapeutics, Inc. (1)
EMBER THERAPEUTICS, INC. - NY (1)
EMULATE THERAPEUTICS, INC. (1)
ENDRA Life Sciences Inc. (4)
Envista Holdings Corp (1)
FEMASYS INC (1)
GenMark Diagnostics, Inc. (1)
GI DYNAMICS, INC. (3)
Glolex, Inc. (3)
Glucose Biosensor Systems (Greater China) Holdings, Inc. (1)
GUIDED THERAPEUTICS INC (4)
HealthCor Catalio Acquisition Corp. (2)
Heart Test Laboratories, Inc. (1)
HELIUS MEDICAL TECHNOLOGIES, INC. (1)
Heska Corporation (1)
Hill-Rom Holdings Inc. (2)
Holly Brothers Pictures, Inc. (1)
Hologic (1)
HYPERION THERAPEUTICS INC (1)
Innovative Eyewear Inc (2)
Inogen, Inc. (1)
InspireMD, Inc. (1)
INSULET CORP (2)
Integrity Applications, Inc. (1)
INTENSITY THERAPEUTICS, INC. (1)
Intuitive Surgical Inc. (1)
INVIVO THERAPEUTICS HOLDINGS CORP. (4)
iRhythm Technologies, Inc. (2)
KEWAUNEE SCIENTIFIC CORP (2)
Lantheus Holdings, Inc. (2)
Lexeo Therapeutics, Inc. (2)
LivaNova (1)
Lucid Diagnostics Inc. (5)
MABVAX THERAPEUTICS HOLDINGS, INC. (1)
MAGNA LAB INC (3)
Medifirst Solutions, Inc. (1)
Medtronic plc (1)
MELINTA THERAPEUTICS, INC. (1)
Meridian Bioscience, Inc. (1)
Merit Medical Systems, Inc. (1)
MICRO THERAPEUTICS INC (1)
Microbot Medical Inc. (1)
MILESTONE SCIENTIFIC INC. (2)
MINERVA SURGICAL INC (1)
MISONIX INC (2)
Modular Medical, Inc. (3)
MRI INTERVENTIONS, INC. (3)
MYOMO INC (3)
NanoVibronix, Inc. (4)
Neumora Therapeutics, Inc. (1)
NeuroMetrix, Inc. (1)
Neuronetics, Inc. (1)
NeuroPace Inc (1)
NEXEON MEDSYSTEMS INC (1)
NuVasive Inc (5)
OBALON THERAPEUTICS INC (4)
Ocera Therapeutics, Inc. (1)
Orexigen Therapeutics, Inc. (2)
Orthofix Medical Inc. (4)
OxySure Therapeutics, Inc. (2)
OZOP SURGICAL CORP. (2)
Pandion Therapeutics Holdco LLC (1)
PERNIX THERAPEUTICS HOLDINGS, INC. (1)
PetVivo Holdings, Inc. (1)
PRECISION OPTICS CORPORATION, INC. (2)
Precision Therapeutics Inc. (2)
Presbia PLC (3)
Primus Therapeutics Inc. (1)
Pulmonx Corp (9)
Ra Medical Systems, Inc. (1)
ReShape Lifesciences Inc. (11)
ResMed (1)
RetinalGenix Technologies Inc. (1)
ROCKWELL MEDICAL, INC. (1)
RxSight, Inc. (3)
SCIENTIFIC INDUSTRIES INC (1)
Semler Scientific, Inc. (1)
Sharps Technology Inc. (3)
ShockWave Medical, Inc. (1)
Sientra, Inc. (8)
Silk Road Medical Inc (1)
Spark Therapeutics, Inc. (1)
STAAR SURGICAL CO (1)
Stereotaxis, Inc. (4)
STRATA Skin Sciences, Inc. (5)
TACTILE SYSTEMS TECHNOLOGY INC (2)
Talis Biomedical Corp (1)
TANDEM DIABETES CARE INC (1)
TearLab Corp (1)
TechCare Corp. (6)
Teleflex Inc (2)
Tenon Medical, Inc. (2)
THC Therapeutics, Inc. (10)
Tobira Therapeutics, Inc. (4)
TRANSENTERIX INC. (4)
United Health Products, Inc. (1)
Valeritas Holdings Inc. (3)
Vector Therapeutics, Inc. (1)
VERMILLION, INC. (12)
Vidara Therapeutics International Ltd (1)
VIVEVE MEDICAL, INC. (3)
VIVOS INC (6)
VOLITIONRX LTD (2)
VYCOR MEDICAL INC (5)
WOUND MANAGEMENT TECHNOLOGIES, INC. (5)
Zander Therapeutics, Inc (2)
Zosano Pharma Corp (3)

Recent Contracts

Consulting Agreement, by and between Envista Holdings Corporation and Barbara Hulit (Envista Holdings Corp, Filed With SEC on March 28, 2024)
Consulting Agreement, dated October 17, 2023, by and between the Company and Alexander Tokman (ENDRA Life Sciences Inc., Filed With SEC on March 28, 2024)
Consulting Agreement dated September 19, 2023, by and between the Company and Mr. Nicols (SCIENTIFIC INDUSTRIES INC, Filed With SEC on March 7, 2024)
Consulting Agreement, dated February 29, 2024, by and between C2C Advisors Inc. and Intelligent Bio Solutions Inc (Glucose Biosensor Systems (Greater China) Holdings, Inc., Filed With SEC on March 1, 2024)
Consulting Agreement with Dan Puckett (ShockWave Medical, Inc., Filed With SEC on February 26, 2024)
Consulting Agreement (CryoLife, Inc., Filed With SEC on February 23, 2024)
Consulting Agreement, dated January 31, 2024 (BioSig Technologies, Inc., Filed With SEC on February 1, 2024)
Transition and Consulting Agreement between the Company and Nadim Yared dated January 30, 2024 (CVRx, Inc., Filed With SEC on January 31, 2024)
Consulting Agreement between the Company and David Roman (Acutus Medical, Inc., Filed With SEC on January 11, 2024)
Transition and Consulting Agreement by and between the Company and David B. Berger, effective December 5, 2023 (TANDEM DIABETES CARE INC, Filed With SEC on December 11, 2023)
Amended and Restated Consulting Agreement, dated as of September 4, 2023, between Nordicus Partners Corporation and Bennett J. Yankowitz (AdvanSource Biomaterials Corp, Filed With SEC on December 6, 2023)
Consulting Agreement by and between RetinalGenix Technologies Inc. and Trendz Network, LLC (RetinalGenix Technologies Inc., Filed With SEC on December 4, 2023)
Amended and Restated Consulting Agreement, dated as of September 4, 2023, between Nordicus Partners Corporation and Bennett J. Yankowitz (AdvanSource Biomaterials Corp, Filed With SEC on November 27, 2023)
Consulting Agreement, by and between the Registrant and Stig Hansen, dated January 31, 2023 (Carmot Therapeutics Inc., Filed With SEC on November 17, 2023)
Amended and Restated Consulting Agreement, dated as of September 4, 2023, between Nordicus Partners Corporation and Bennett J. Yankowitz (AdvanSource Biomaterials Corp, Filed With SEC on November 13, 2023)
Consulting Agreement, dated November 1, 2023, by and between Pulmonx Corporation and Derrick Sung (Pulmonx Corp, Filed With SEC on November 3, 2023)
Consulting Agreement dated as of November 2, 2023 between Silk Road Medical, Inc. and Erica J. Rogers (Silk Road Medical Inc, Filed With SEC on November 2, 2023)
Amended and Restated Consulting Agreement, dated as of September 4, 2023, between Nordicus Partners Corporation and Bennett J. Yankowitz (AdvanSource Biomaterials Corp, Filed With SEC on October 24, 2023)
Consulting Agreement dated October 11, 2023, by and between GlucoTrack, Inc. and James S. Cardwell (Integrity Applications, Inc., Filed With SEC on October 12, 2023)
Consulting Agreement, dated as of September 30, 2023, by and between Hyperfine, Inc. and Khan Siddiqui, M.D (HealthCor Catalio Acquisition Corp., Filed With SEC on October 3, 2023)
Consulting Agreement between the Company and JKrier LLC, effective as of October 1, 2023 (DYNATRONICS CORP, Filed With SEC on October 2, 2023)
Consulting Agreement, dated July 16, 2021, between LEXEO Therapeutics, LLC and Eric Adler, M.D (Lexeo Therapeutics, Inc., Filed With SEC on September 29, 2023)
Consulting Agreement, dated October 9, 2020, between LEXEO Therapeutics, LLC and Ronald G. Crystal, M.D (Lexeo Therapeutics, Inc., Filed With SEC on September 29, 2023)
Amended and Restated Consulting Agreement, dated as of September 4, 2023, between Nordicus Partners Corporation and Bennett J. Yankowitz (AdvanSource Biomaterials Corp, Filed With SEC on September 19, 2023)
Amended Consulting Agreement between Aspira Womens Health Inc. and NuPath, LLC (VERMILLION, INC., Filed With SEC on September 12, 2023)
Consulting Agreement, dated as of May 20, 2023, by and between the Registrant and John Dunlop, Ph.D (Neumora Therapeutics, Inc., Filed With SEC on August 25, 2023)
Consulting Agreement dated August 4, 2023 by and between Nuwellis, Inc. and Lynn Blake (CHF Solutions, Inc., Filed With SEC on August 8, 2023)
Consulting Agreement between the Company and West Boulder LLC (EMULATE THERAPEUTICS, INC., Filed With SEC on July 10, 2023)
Consulting Agreement dated June 28, 2023, by and between NeuroPace and Michael Favet (NeuroPace Inc, Filed With SEC on June 28, 2023)
Consulting Agreement between Alessandra Pavesio and Bioventus LLC, dated as of January 1, 2023 (Bioventus Inc., Filed With SEC on May 16, 2023)
Consulting Agreement by and between Cutera, Inc. and David Mowry, effective May 11, 2023 (Cutera, Inc., Filed With SEC on May 12, 2023)
Resignation, Release and Consulting Agreement, dated March 10, 2023, by and between the Registrant and Douglas Devin (iRhythm Technologies, Inc., Filed With SEC on May 4, 2023)
Consulting Services Agreement by and between the Company and Bret Christensen dated May 2, 2023 (INSULET CORP, Filed With SEC on May 4, 2023)
Consulting Agreement, dated as of April 1, 2023, between EKIMAS Corporation and Bennett J. Yankowitz (AdvanSource Biomaterials Corp, Filed With SEC on May 3, 2023)
Consulting Agreement, dated March 31, 2023, by and between the Company and Ms. Kathleen P. Bloch (Cytosorbents Corp, Filed With SEC on April 6, 2023)
Consulting Services Agreement by and between the Company and Charles J. Alpuche (INSULET CORP, Filed With SEC on February 22, 2023)
Consulting Agreement (Francis Knuettel II) (Chromocell Therapeutics Corp, Filed With SEC on January 20, 2023)
Consulting Agreement, dated December 27, 2022, by and between the Company and David Clapper (MINERVA SURGICAL INC, Filed With SEC on December 28, 2022)
Mason Consulting Agreement (STAAR SURGICAL CO, Filed With SEC on December 19, 2022)
Advisory Board Consulting Agreement, dated October 31, 2022, by and between the registrant and Claire M. Fraser (Becton Dickinson, Filed With SEC on November 22, 2022)